Biotest AG BIOTEST ORD SHS
Biotest AG BIOTEST ORD SHS/ DE0005227201 /
0N6Z
|
- -
|
Var.
-
|
Volume |
Denaro06:00:05 |
Lettera06:00:05 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
-EUR
|
-
|
-
Fatturato: - |
-Quantità in denaro: - |
-Quantità in lettera: - |
2.43 bill.EUR |
- |
12.81 |
Descrizione business
Biotest is a provider of plasma proteins and biotherapeutic drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the indications of rheumatoid arthritis and cancer of plasma cells, which are produced by recombinant technologies.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Peter Janssen |
| Consiglio di amministrazione |
| Ainhoa Mendizabal Zubiaga, Dr. Jörg Schüttrumpf, Dr. Michael Ramroth, Dr. Georg Floß |
| Consiglio di sorveglianza |
| Dr. Bernhard Ehmer, David Bell, Uta Kemmerich-Keil, Jürgen Heilmann, Dirk Schuck, Raimon Grifols Roura |
Dati aziendali
| Name: |
Biotest AG |
| Indirizzo: |
Landsteinerstraße 5,D-63303 Dreieich |
| Telefono: |
+49-6103-801-0 |
| Fax: |
+49-6103-801-150 |
| E-mail: |
mail@biotest.de
|
| Internet: |
www.biotest.de |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
14/10/1987 |
Rapporti con gli investitori
| Name: |
Dr. Monika Buttkereit |
| IR telefono: |
+49-6103-801-4406 |
| IR Fax: |
+49-6103-801-347 |
| IR e-mail: |
investor_relations@biotest.de
|
